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SummAry
Dacryocystorhinostomy allows by-passing saccal and post-saccal stenoses and has traditionally been performed via an external ap-
proach, namely, external dacryocystorhinostomy. over the past two decades, advances in endoscopic equipment have led to the 
widespread use of the endoscopic transnasal approach to the lacrimal pathway. A retrospective evaluation has been made of personal 
success rates in endoscopic dacryocystorhinostomy without stenting in 56 patients (15 male, 41 female) treated for nasolacrimal 
duct obstruction (48 unilateral, 8 bilateral). of these, 53 were primary endoscopic dacryocystorhinostomy and 11 procedures were 
revisions of external dacryocystorhinostomy. A total of 64 endoscopic dacryocystorhinostomies were performed. mean follow-up 
was 37.3 months (range 12-84 months). The success of surgery was defined by resolution of signs (epiphora and dacryocystitis) and 
objectively by endoscopic evaluation of the rhinostomy on routine follow-up. results from patients undergoing primary endoscopic 
dacryocystorhinostomy were better than those for revision of external dacryocystorhinostomy with overall anatomical and functional 
results of 94.3% and 90.9%, in our series. The present study confirms that endoscopic dacryocystorhinostomy without stenting is ef-
fective for the treatment of nasolacrimal duct obstruction. The endoscopic approach allows simultaneous treatment of associated ana-
tomic anomalies and sino-nasal disorders. results obtained confirm that a functionally patent dacryocystorhinostomy can be achieved 
without the need for routine nasolacrimal stenting.
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riASSunTo
La dacriocistorinostomia (DCR) è un intervento chirurgico che consente di by-passare una stenosi saccale e post-saccale e viene tradi-
zionalmente eseguita con approccio esterno (ExDCR). Nelle ultime due decadi, i miglioramenti della chirurgia endoscopica nasale hanno 
consentito il suo utilizzo nella patologia delle vie lacrimali. Abbiamo valutato, retrospettivamente, i nostri risultati in 56 pazienti (15 ma-
schi, 41 femmine) affetti da ostruzione del dotto naso-lacrimale (48 unilaterali, 8 bilaterali) e sottoposti ad intervento chirurgico di dacrio-
cistorinostomia endoscopica (EnDCR) senza l’utilizzo dello stent naso-lacrimale. Di questi 53 erano EnDCR primarie e 11 erano revisioni 
di ExDCR, per un totale di 64 EnDCR. Il follow-up medio è stato di 37,3 mesi (range 12-84 mesi). Il successo dell’intervento chirurgico è 
stato definito dalla risoluzione dei segni (epifora e dacriocistiti) ed obiettivamente dalla valutazione endoscopica del rinostoma durante il 
follow-up. Nella nostra serie, i risultati nei pazienti sottoposti a EnDCR primaria sono stati migliori rispetto a quelli sottoposti a revisione 
di ExDCR con un complessivo risultato anatomico e funzionale del 94,3% e 90,9%. Il presente studio conferma che anche senza l’utilizzo 
dello stent naso-lacrimale a seguito di un intervento di EnDCR, si possono ottenere dei buoni risultati nel trattamento delle ostruzioni del 
dotto naso-lacrimale. Inoltre, l’approccio endoscopico, consente di trattare contemporaneamente anomalie anatomiche e patologie rino-
sinusali. Noi crediamo che un dacriocistorinostoma funzionale può essere ottenuto senza la necessità di inserire routinariamente uno stent 
naso-lacrimale.
PArole ChiAve: Dacriocistorinostomia • Stent in silicone • Vie lacrimali • Chirurgia endoscopica
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Introduction
lacrimal pathway obstruction can be idiopathic or sec-
ondary  to  chronic  infections,  tumours,  trauma  or  ia-
trogenic factors, and may occur at any point along the 
tract, being more frequent, however, at the level of the 
nasolacrimal duct. obstruction can be pre-saccal (usu-
ally common canaliculus), saccal and post-saccal (na-
solacrimal duct). Bilateral nasolacrimal duct obstruc-
tion is much less common than unilateral obstruction endoscopic transnasal dacryocystorhinostomy without stenting
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and sometimes this is associated with nasal and sinus 
diseases 1.
Dacryocystorhinostomy (DCr) is indicated for saccal and 
post-saccal stenosis and is traditionally performed exter-
nally by ophthalmologists 2. over the past two decades, 
advances in endoscopic equipment have led to a spread 
of the endoscopic transnasal approach by otorhinolaryn-
gologists with results comparable to the external approach 
and the potential for less morbidity 3 4.
The  advantages  of  endoscopic  Dacryocystorhinostomy 
(enDCr) with respect to external Dacryocystorhinosto-
my (exDCr) include the lack of skin incision, short op-
erating time, and lower risk of interfering with the physi-
ological lacrimal pump mechanism, minimal blood loss 
and the possibility to correct associated intra-nasal patho-
logical conditions during the same procedure 3.
naso-lacrimal  silicone  stenting  is  performed  by  many 
surgeons as a routine step in exDCr and enDCr 3. The 
function of the stent is thought to be useful in keeping 
the neo-ostium patent in the initial stages of healing and 
thus decreasing the chance of early failure. Personal ex-
perience is reported in 64 consecutive cases submitted to 
enDCr without stenting.
Material and methods
Between march 1996 and September 2008, 56 patients 
(15 male, 41 female) were treated for naso-lacrimal duct 
obstruction by the same surgeon (rP). mean age was 59.2 
years (range 13-86). of these patients, 54 had an idiopath-
ic obstruction, one was post-traumatic and one secondary 
to fibrosis following radiotherapy for carcinoma of the 
nasal cavity. Patients presented with only epiphora in 32 
cases (50%), recurrent dacryocystitis in 25 cases (39%), 
lacrimal abscess in 6 cases (9.3%), and a combination of 
symptoms (epiphora, purulent secretion from the canalic-
ula, nasal obstruction and nasal discharge) in one (1.6%).
Patients underwent clinical evaluation consisting of oph-
thalmologic  and  otorhinolaryngological  examinations 
(including nasal endoscopy using 0° and 45° rigid en-
doscopes).  each  patient  had  a  routine  antero-posterior 
and lateral dacryocystography with lipiodol (iodinated, 
radio-opaque  contrast  solution),  laboratoire  guerbet, 
Paris, France, to determine the level of the obstruction. 
Computed Tomography (CT) sinus scan was performed 
to assess the anatomy and possible cause of obstruction. 
This also allowed to identify the extent of concomitant 
sino-nasal pathology or anatomical changes (i.e., agger 
nasi) that could be managed upon at the same time.
overall, there were 64 enDCrs of which 53 were primary 
enDCr (25 right, 28 left). A total of 11 procedures were 
revisions of exDCr (8 right, 3 left) and one of these was a 
revision of an enDCr performed in another centre. Thus 
a total of 8 bilateral and 48 unilateral procedures were 
performed (Table i).
Septoplasty or access septal surgery was performed in 3 
cases. middle turbinoplasty was required in 7 patients, for 
better exposure of the surgical area, 4 middle meatal an-
trostomies for maxillary sinusitis and 1 nasal polypecto-
my, were also performed. All procedures were performed 
in day surgery.
mean follow-up was 37.3 months (range 12-84 months).
Surgical technique
All procedures were performed under general anaesthetic, 
using 0° and 45° rigid endoscopes (Karl Storz, Tuttlingen, 
germany) connected to a high-resolution video system 
(endovision, Tricam Sl ii, Karl Storz, Tuttlingen, ger-
many). neurosurgical patties soaked with 1:1000 adrena-
line or xylometazoline hydrochlorate were placed in the 
nose for 5 minutes to achieve local vasoconstriction. Sub-
mucosal injection of lignospan (2% lignocaine, 1:80.000 
adrenaline) anterior to the axilla of the middle turbinate 
was performed to produce hydro dissection and vasocon-
striction of the mucosal flap. The introduction of a 0.7 mm 
diameter light lacrimal probe via the inferior punctum al-
lowed accurate endonasal identification of the medial sac-
cal wall. The mucosal incision was made 5 to 10 mm ante-
rior to the attachment of the middle turbinate with a sickle 
knife. A posteriorly based mucosal flap was elevated and 
the bone corresponding to nasal projection of the lacrimal 
sac was removed. The thick bone from the frontal process 
of the maxilla was removed with Smith-Kerrison forceps. 
when it was too difficult to use the forward blade of the 
forceps, we used a cutting or diamond drill burr to com-
plete the bone removal and exposure of the medial sac 
wall. once the sac was exposed, a posterior vertical inci-
sion of the wall of the sac was performed with a Beaver 
Table I. Procedures (total number = 64) performed.
Procedure Unilateral Bilateral Eyes Second procedure
 L  R
Primary EnDCR 37  8 28 25 2 (with stent)
EnDCR Revision of ExDCR * 11 * 0 3 8 1
Total 48 8 31 33 3
EnDCR: Endoscopic Dacryocystorhinostomy; ExDCR: External Dacryocystorhinostomy; * 1 Revision EnDCR performed in another Department.B. Pittore et al.
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angle knife. This creates anteriorly large, and posteriorly, 
small based flaps, thereby marsupialising the sac and cov-
ering the exposed bone as much as possible. The mean 
duration of the procedure was 40 minutes. when possible, 
the sac was widely marsupialised and the flaps kept in 
place with a gelatine based absorbable haemostat, namely, 
Spongostan® (Ferrosan, Soeborg, Denmark).
Sino-nasal pathology was corrected when necessary and 
in cases of significant bleeding, nasal packing for < 24 
hours was used.
Post-operative care
The  post-operative  treatment  included  oral  antibiotics, 
usually Co-amoxiclav (Amoxicillin and Clavulanic Acid) 
625 mg three times daily for 7 days and topical eye drops 
(betamethasone  0.2  g  and  chloramphenicol  0.5  g)  2-3 
drops, 3 times daily, for 7 days. nasal douching with isot-
onic sterile solution, three times a day, was prescribed. in 
the postoperative period, the patients underwent regular 
rigid nasoendoscopy examinations for debridement of fi-
brinous exudates, normally every 4-5 days for the first two 
weeks, thereafter, patients were examined on a monthly 
basis for the first 3 months and then every six months for 
the second year. Complete epithelialisation of the rhinos-
tomy occurred within two months (Fig. 1), but the final 
diameter of the rhinostomy was only considered stable at 
8-12 months after surgery (Fig. 2).
Results
Surgical success was defined by resolution of signs and 
symptoms,  rhinostomy  stabilization  and  free  lacrimal 
drainage. A modified 5-point likert Scale 5 was used to 
assess subjective changes in symptoms.
The patients were asked about the degree of the epiphora 
and improvement of the symptoms. Declaration of improve-
ment, on the modified likert Scale, with a score of 1 to 3 was 
considered successful. Functional success was observed in 
60/64 cases (93.7%). of these, 58 were without epiphora 
and 2 reported an improvement in symptoms (Table ii). our 
anatomical success, including revision surgery, showed that, 
in 60/64 cases, the rhinostomy was patent leading to an over-
all anatomical success rate of 93.7% (Table iii). results in 
patients undergoing primary enDCr were better than those 
for revision of exDCr, with an anatomical and functional 
success rate of 94.3% (Tables ii, iii). results following revi-
sion of exDCr were 90.9% including one patient who was 
submitted to a second procedure (Tables ii, iii).
Complications
no major complications occurred intra-operatively. one 
post-operative septal haematoma occurred, that was treat-
Fig. 1. Dacryocystorhinostoma 2 months after the procedure. Presence of 
some granulation tissue at the anterior margin of the stoma.
Fig. 2. Dacryocystorhinostoma 6 months after the procedure. Patient previ-
ously treated with radiotherapy for naso-sinusal carcinoma.
Table II. Subjective (functional) results: modified Likert Scale.
Likert Scale Primary EnDCR EnDCR Revision 
of ExDCR *
Score 1
(No symptoms)
48 10
Score 2
(Significant improvement)
2 0
Score 3
(Slight improvement)
0 0
Score 4
(No improvement)
3 1
Score 5
(Worsening of symptoms)
0 0
Results 50/53 (94.3%) 10/11 (90.9%)
Total results 60/64 (93.7%)
* 1 Revision EnDCR performed in another Department.endoscopic transnasal dacryocystorhinostomy without stenting
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ed with incision and drainage, one epistaxis, treated con-
servatively, and 4 cases of latero-septal synechia which, 
however, did not interfere with functional outcome or re-
quire further treatment.
Discussion
exDCr, originally described by Toti in 1904 6 has a suc-
cessful rate, when performed by properly trained oph-
thalmologists,  of  about  90% 3  4.  endo-nasal  DCr  was 
described prior to this, in 1893 by Caldwell 7, but poor 
equipment and subsequent good results from the external 
approach led it to being abandoned. mcDonogh and meir-
ing were the first modern surgeons credited with introduc-
ing endoscopic transnasal DCr in the late 1980s 8.
enDCr has a success rate of 83-94% 9 10, and has been 
demonstrated to offer similar outcomes when compared 
to exDCr, with low complication rates 3 4. enDCr is a 
good option for the treatment of primary nasolacrimal 
duct obstruction but it is also considered an acceptable 
procedure for the treatment of failure of exDCr 11.
The advantages of enDCr with respect to exDCr include 
avoiding an external scar, less interference on the lacrimal 
pump mechanism and the possibility to treat sino-nasal 
disorders and anatomical abnormalities in the same op-
eration 12. in the present series, we performed 15 ancillary 
procedures (3 septoplasty or access upper septal surgery, 
7 middle turbinoplasty, 4 middle meatal antrostomies and 
in one nasal polypectomy) that would not have been pos-
sible if an exDCr had been performed.
Pre-operative evaluation has been standardized with oph-
thalmologic evaluation and diagnosis including a dacryo-
cystography with contrast medium to confirm the site of 
the obstruction. endoscopic evaluation is performed at the 
same time as the enT evaluation and the need for CT is 
discussed on the basis of the clinical findings at rhinos-
copy. we performed a CT scan in 48 patients (85.7%) in 
order to better assess the anatomy and, if present, the de-
gree of sino-nasal polyposis. in our opinion, CT should 
be considered a useful tool in the pre-operative planning 
of the procedure whether for the endoscopic or external 
approach, in the latter allowing the ophthalmologist to in-
volve a rhinologist in the event of sinonasal pathology or 
anatomical changes that can have an effect upon the sur-
gical results. in the early years of the present experience, 
a CT scan was not routinely performed pre-operatively, 
whereas it is now our policy to obtain a CT scan pre-
operatively in order to correctly define the cause of the 
obstruction of the lacrimal pathways.
in our department, different types of mucosal flaps were 
used over time. we believe that the posterior mucosal flap 
offers the best possibility for easy access to the bone over-
lying the sac, allowing wide and complete exposure of the 
medial wall of the sac that can thus be marsupialised. This 
represents a key point in the procedure that assists in the 
creation of a large rhinostomy that obviates the need for 
silicone stenting.
inadequate bone removal is also a common cause of fail-
ure 9. various instruments can be used to remove the bone 
including drill (cutting or diamond burr), curette, Smith-
Kerrison forceps or laser (KTP, Diode, Argon, holmium: 
yAg, Co2) 13 14. Smith-Kerrison forceps are a safe and 
effective tool to obtain a wide DCr although, in some 
instances, it is not adequate, for the easy removal of the 
superior aspect of the frontal process of the maxillary 
bone for anatomical reasons, since the forceps can not 
incarcerate the bone in these cases we would favour pow-
ered drills.
The size of the lacrimal sac, at the time of the surgery, 
has a direct influence on the success of the procedure as 
described in the literature 15. in a group of 49 patients 
undergoing enDCr, mann reported that the neo-ostium 
was reduced in size in the first 4 weeks after surgery, 
thereafter, the ostium dimensions appear to be stable 15. 
we now tend to expose and marsupialize the sac entirely 
and to keep the flaps in place with Spongostan®, a gel-
atine-based  absorbable  haemostat  (Ferrosan,  Soeborg, 
Denmark).
The use of silicone stents is considered routine in many 
institutions 3. Although controversial, silicone stents are 
used to keep the neo-ostium open after the procedure 
and are thought to maintain the patency of the ostium 
by preventing circular stenosis of the neo-ostium in the 
post-operative healing period. Prolonged silicone intu-
bation adds to the risk of granulation tissue formation 
at the neo-ostium, and has been described as a cause of 
failure 9 16. There is no general agreement regarding the 
duration of the stenting. recommendations range from 
4  weeks  to  3  months.  Prolonged  intubation  has  been 
recommended in the treatment of functional failure of 
exDCr or enDCr. The bicanalicular tubes are used as 
long-standing stenting. The efficacy seems to be related 
to the passage of the tears in the nose for micro-capil-
larity 17. Clearly, this is an area that could benefit from 
further investigation.
in recent years, a number of Authors have described enD-
Cr without silicone stenting 10 18-20. Smirnov demonstrated 
in a prospective randomized trial of patients undergoing 
primary enDCr that silicone stenting is unnecessary, giv-
Table III. Total anatomical results.
Patency Primary EnDCR EnDCR Revision of 
ExDCR *
Rhinostomy open 50 10
Rhinostomy closed  3  1
Results  50/53 (94.3%)  10/11 (90.9%)
Total results  60/64 (93.7%)
* 1 Revision EnDCR performed in another Department.B. Pittore et al.
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ing an overall success rate with and without silicon tubes 
of 78% and 100% respectively 10. This trial showed statis-
tically significant results favouring non-stenting. This has 
been confirmed recently in another randomised trial by 
unlu et al. showing results in the stented and non-stented 
groups of 84.2% and 94.7%. Although there was no sta-
tistical difference showing one technique to be superior to 
another, the Authors recommended that silicone intubation 
was not a mandatory requirement following enDCr 20. in 
the present series, the silicone stent was never inserted 
thus allowing the opportunity of reducing the costs of the 
procedure and minimizing the discomfort for the patient, 
without negatively affecting the outcome.
Conclusions
our results confirm that enDCr without stenting is effec-
tive for the treatment of naso-lacrimal duct obstruction. 
This procedure gives good anatomic and functional re-
sults, with low complication rates. The endonasal endo-
scopic approach allows simultaneous treatment of associ-
ated anatomic anomalies and sino-nasal pathology. in the 
present series of 64 consecutive procedures, a functionally 
patent dacryocystorhinostomy was achieved without the 
need for nasolacrimal stent insertion. Taking into account 
the added cost and potential morbidity, we suggest that the 
use of nasolacrimal stents, in enDCr, can be avoided.
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